Skip to main content

Table 1 Characteristics of patients in the cancer and control groups

From: The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study

CharacteristicsBefore matchingAfter matching
Cancer group (n = 51)Control group (n = 5497)P valueCancer group (n = 51)Control group (n = 204)P value
Age, median4735< 0.000147460.69
Female gender, n (%)49, 96.084930, 89.680.205549, 96.08192,94.120.74
Age at SLE diagnosis, median41330.002441390.96
Disease course of SLE, median606< 0.000160600.92
Hypertension5, 9.80%199, 3.620%0.01955, 9.80%15, 7.35%0.56
Diabetes mellitus5, 9.80%189, 3.438%0.03755, 9.80%14, 6.86%0.55
Dyslipidemia8, 15.38%494, 8.18%0.09698, 15.38%28, 13.72%0.72